Skip to content

PET Imaging of Solid Tumors Using the FAP-Targeted Probe 18F/68Ga-FAPI

PET Imaging of Solid Tumors Using the FAP-Targeted Probe 18F/68Ga-FAPI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111549
Enrollment
Unknown
Registered
2025-11-03
Start date
2025-04-10
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumors (including but not limited to lung cancer, esophageal cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer, cervical cancer, and ovarian cancer).

Interventions

Gold Standard:Pathological diagnosis
Index test:18F/68Ga-FAPI PET/CT Imaging Diagnosis

Sponsors

Shandong First Medical University and Shandong Academy of Medical Sciences (Shandong Cancer Hospital &Institute)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged 18 years or older, regardless of gender. 2.Patients with solid tumors who have not received any antitumor therapy within 1 month and are scheduled for differentiation between benign and malignant lesions, initial staging, response evaluation, or recurrence monitoring. 3.At least one measurable target lesion according to the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. 4.Life expectancy of greater than 3 months.

Exclusion criteria

Exclusion criteria: 1.Severe impairment of liver or renal function (e.g., AST/ALT > 10 times the upper limit of normal, eGFR < 30 mL/min/1.73m^2). 2.Women who are pregnant, lactating, or planning a pregnancy. 3.Inability to lie flat for the duration of the imaging procedure (approximately 30 minutes). 4.History of claustrophobia or other significant psychiatric disorders. 5.Inability to tolerate the complete clinical imaging procedures. 6.Any other condition deemed by the investigator to make the subject unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Accuracy.;

Countries

China

Contacts

Public ContactCuicui Li

Shandong First Medical University and Shandong Academy of Medical Sciences (Shandong Cancer Hospital &Institute)

licuicui199111@sina.com+86 531 67626462

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026